Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib® versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]
暂无分享,去创建一个
C. von Kalle | C. Heining | H. Glimm | P. Schemmer | M. Büchler | D. Jaeger | J. Schmidt | B. Radeleff | G. Richter | C. Kalle | Jan Schmidt | K. Hoffmann | I. Schenkel | G. Richter | A. Zahlten-Hinguranage | P. Schirrmacher | D. Jaeger | M. Büchler | Hanno Glimm | Katrin Hoffmann | Boris Radeleff | Christoph Heining | Dirk Jaeger | C von Kalle | Peter Schemmer | Christoph Heining | Hanno Glimm | M. W. Büchler | Peter Schemmer | Katrin Hoffmann | G. M. Richter | I. Schenkel | A. Zahlten-Hinguranage | P. Schirrmacher | Jan Schmidt | Dirk Jaeger